0001367644-20-000012.txt : 20200225
0001367644-20-000012.hdr.sgml : 20200225
20200225162831
ACCESSION NUMBER: 0001367644-20-000012
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200221
FILED AS OF DATE: 20200225
DATE AS OF CHANGE: 20200225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hauer Jerome M
CENTRAL INDEX KEY: 0001294935
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33137
FILM NUMBER: 20651060
MAIL ADDRESS:
STREET 1: 4435 EASTGATE MALL
STREET 2: SUITE 400
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Emergent BioSolutions Inc.
CENTRAL INDEX KEY: 0001367644
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 141902018
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
BUSINESS PHONE: 240-631-3200
MAIL ADDRESS:
STREET 1: 400 PROFESSIONAL DR, SUITE 400
CITY: GAITHERSBURG
STATE: MD
ZIP: 20879
4
1
wf-form4_158266609423712.xml
FORM 4
X0306
4
2020-02-21
0
0001367644
Emergent BioSolutions Inc.
EBS
0001294935
Hauer Jerome M
400 PROFESSIONAL DR, SUITE 400
GAITHERSBURG
MD
20879
1
0
0
0
Common Stock
2020-02-21
4
S
0
6572
70
D
11752
D
Consists of restricted stock units granted under the Company's stock incentive plan, as amended and restated.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Hauer.
/s/ S. Scott Lieberman, Attorney-in-fact
2020-02-25